These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26385370)

  • 1. Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.
    Li W; Sasso EH; van der Helm-van Mil AH; Huizinga TW
    Rheumatology (Oxford); 2016 Feb; 55(2):357-66. PubMed ID: 26385370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Brahe CH; Østergaard M; Johansen JS; Defranoux N; Wang X; Bolce R; Sasso EH; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll C; Jørgensen A; Krintel SB; Raun J; Hetland ML
    Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study.
    Markusse IM; Dirven L; van den Broek M; Bijkerk C; Han KH; Ronday HK; Bolce R; Sasso EH; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
    J Rheumatol; 2014 Nov; 41(11):2114-9. PubMed ID: 25128518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies.
    Roodenrijs NMT; de Hair MJH; Wheater G; Elshahaly M; Tekstra J; Teng YKO; Lafeber FPJG; Hwang CC; Liu X; Sasso EH; van Laar JM
    Arthritis Res Ther; 2018 Nov; 20(1):256. PubMed ID: 30458871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies.
    Curtis JR; Weinblatt ME; Shadick NA; Brahe CH; Østergaard M; Hetland ML; Saevarsdottir S; Horton M; Mabey B; Flake DD; Ben-Shachar R; Sasso EH; Huizinga TW
    Arthritis Res Ther; 2021 Jan; 23(1):1. PubMed ID: 33397438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.
    Hirata S; Li W; Kubo S; Fukuyo S; Mizuno Y; Hanami K; Sawamukai N; Yamaoka K; Saito K; Defranoux NA; Tanaka Y
    Mod Rheumatol; 2016 Nov; 26(6):850-856. PubMed ID: 26873570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression.
    van der Helm-van Mil AH; Knevel R; Cavet G; Huizinga TW; Haney DJ
    Rheumatology (Oxford); 2013 May; 52(5):839-46. PubMed ID: 23287359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies.
    Curtis JR; Brahe CH; Østergaard M; Lund Hetland M; Hambardzumyan K; Saevarsdottir S; Wang X; Flake Ii DD; Sasso EH; Huizinga TW
    Curr Med Res Opin; 2019 Sep; 35(9):1483-1493. PubMed ID: 30777458
    [No Abstract]   [Full Text] [Related]  

  • 9. A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study.
    Hirata S; Li W; Defranoux N; Cavet G; Bolce R; Yamaoka K; Saito K; Tanaka Y
    Mod Rheumatol; 2015 May; 25(3):344-9. PubMed ID: 25295918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
    Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF
    Ann Rheum Dis; 2015 Jun; 74(6):1102-9. PubMed ID: 24812287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes.
    Bouman CAM; van der Maas A; van Herwaarden N; Sasso EH; van den Hoogen FHJ; den Broeder AA
    Rheumatology (Oxford); 2017 Jun; 56(6):973-980. PubMed ID: 28339738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
    Reiss WG; Devenport JN; Low JM; Wu G; Sasso EH
    Rheumatol Int; 2016 Feb; 36(2):295-300. PubMed ID: 26026604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study.
    Bakker MF; Cavet G; Jacobs JW; Bijlsma JW; Haney DJ; Shen Y; Hesterberg LK; Smith DR; Centola M; van Roon JA; Lafeber FP; Welsing PM
    Ann Rheum Dis; 2012 Oct; 71(10):1692-7. PubMed ID: 22596166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia.
    Lee YC; Hackett J; Frits M; Iannaccone CK; Shadick NA; Weinblatt ME; Segurado OG; Sasso EH
    Rheumatology (Oxford); 2016 Apr; 55(4):640-8. PubMed ID: 26608972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis.
    Curtis JR; Flake DD; Weinblatt ME; Shadick NA; Østergaard M; Hetland ML; Brahe CH; Hwang YG; Furst DE; Strand V; Etzel CJ; Pappas DA; Wang X; Hwang CC; Sasso EH; Gutin A; Hitraya E; Lanchbury JS
    Rheumatology (Oxford); 2019 May; 58(5):874-883. PubMed ID: 30590790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort.
    Mueller RB; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
    Rheumatology (Oxford); 2014 Apr; 53(4):671-7. PubMed ID: 24352338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.
    Vastesaeger N; Xu S; Aletaha D; St Clair EW; Smolen JS
    Rheumatology (Oxford); 2009 Sep; 48(9):1114-21. PubMed ID: 19589891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
    Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
    Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.